Recent analyses of head and neck squamous cell carcinoma [36] and breast cancer [37] have also revealed that responders to anti-PD-1 therapy exhibit higher expression of cytotoxicity genes in exhausted CD8+ T cells compared to non-responders. The gene discussed is CD8A; the disease is breast carcinoma.